Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiomics-based Diagnosis, Treatment and Outcome Prediction for Pituitary Adenoma

NCT06234553 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT06234553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06234553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiomics-based Diagnosis, Treatment and Outcome Prediction for Pituitary Adenoma
Lead sponsor
Beijing Tiantan Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
December 31, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pituitary adenoma